11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Cameron, David, Prof, Piccart-Gebhart, Martine J, PhD, Gelber, Richard D, PhD, Procter, Marion, PhD, Goldhirsch, Aron, MD, de Azambuja, Evandro, MD, Castro, Gilberto, MD, Untch, Michael, MD, Smith, Ian, MD, Gianni, Luca, MD, Baselga, Jose, MD, Al-Sakaff, Nedal, PhD, Lauer, Sabine, PhD, McFadden, Eleanor, MA, Leyland-Jones, Brian, MBBS, Bell, Richard, MBBS, Dowsett, Mitch, PhD, Jackisch, Christian, MD
Published in The Lancet (British edition) (25.03.2017)
Published in The Lancet (British edition) (25.03.2017)
Get full text
Journal Article
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Kuehn, Thorsten, Prof, Bauerfeind, Ingo, MD, Fehm, Tanja, Prof, Fleige, Barbara, MD, Hausschild, Maik, MD, Helms, Gisela, MD, Lebeau, Annette, MD, Liedtke, Cornelia, MD, Minckwitz, Gunter von, Prof, Nekljudova, Valentina, PhD, Schmatloch, Sabine, MD, Schrenk, Peter, MD, Staebler, Annette, MD, Untch, Michael, Prof
Published in The lancet oncology (01.06.2013)
Published in The lancet oncology (01.06.2013)
Get full text
Journal Article
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
VON MINCKWITZ, Gunter, UNTCH, Michael, JACKISCH, Christian, KAUFMANN, Manfred, KONECNY, Gottfried E, DENKERT, Carsten, NEKLJUDOVA, Valentina, MEHTA, Keyur, LOIBL, Sibylle, BLOHMER, Jens- Uwe, COSTA, Serban D, EIDTMANN, Holger, FASCHING, Peter A, GERBER, Bernd, EIERMANN, Wolfgang, HILFRICH, Jörn, HUOBER, Jens
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
Piccart-Gebhart, Martine, Holmes, Eileen, Baselga, José, de Azambuja, Evandro, Dueck, Amylou C, Viale, Giuseppe, Zujewski, Jo Anne, Goldhirsch, Aron, Armour, Alison, Pritchard, Kathleen I, McCullough, Ann E, Dolci, Stella, McFadden, Eleanor, Holmes, Andrew P, Tonghua, Liu, Eidtmann, Holger, Dinh, Phuong, Di Cosimo, Serena, Harbeck, Nadia, Tjulandin, Sergei, Im, Young-Hyuck, Huang, Chiun-Sheng, Diéras, Véronique, Hillman, David W, Wolff, Antonio C, Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Gomez, Henry, Suter, Thomas, Gelber, Richard D, Perez, Edith A
Published in Journal of clinical oncology (01.04.2016)
Published in Journal of clinical oncology (01.04.2016)
Get full text
Journal Article
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Stevic, Ines, Müller, Volkmar, Weber, Karsten, Fasching, Peter A, Karn, Thomas, Marmé, Frederic, Schem, Christian, Stickeler, Elmar, Denkert, Carsten, van Mackelenbergh, Marion, Salat, Christoph, Schneeweiss, Andreas, Pantel, Klaus, Loibl, Sibylle, Untch, Michael, Schwarzenbach, Heidi
Published in BMC medicine (10.10.2018)
Published in BMC medicine (10.10.2018)
Get full text
Journal Article
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
von Minckwitz, Gunter, Prof, Schneeweiss, Andreas, Prof, Loibl, Sibylle, Prof, Salat, Christoph, MD, Denkert, Carsten, Prof, Rezai, Mahdi, Prof, Blohmer, Jens U, Prof, Jackisch, Christian, Prof, Paepke, Stefan, MD, Gerber, Bernd, Prof, Zahm, Dirk M, MD, Kümmel, Sherko, MD, Eidtmann, Holger, MD, Klare, Peter, MD, Huober, Jens, Prof, Costa, Serban, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Hilfrich, Jörn, Prof, Khandan, Fariba, MD, Fasching, Peter A, Prof, Sinn, Bruno V, MD, Engels, Knut, MD, Mehta, Keyur, MBA, Nekljudova, Valentina, PhD, Untch, Michael, Prof
Published in The lancet oncology (01.06.2014)
Published in The lancet oncology (01.06.2014)
Get full text
Journal Article
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
Ingold Heppner, Barbara, Untch, Michael, Denkert, Carsten, Pfitzner, Berit M, Lederer, Bianca, Schmitt, Wolfgang, Eidtmann, Holger, Fasching, Peter A, Tesch, Hans, Solbach, Christine, Rezai, Mahdi, Zahm, Dirk M, Holms, Frank, Glados, Manfred, Krabisch, Petra, Heck, Esther, Ober, Angelika, Lorenz, Petra, Diebold, Kurt, Habeck, Jörg-Olaf, Loibl, Sibylle
Published in Clinical cancer research (01.12.2016)
Published in Clinical cancer research (01.12.2016)
Get full text
Journal Article
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
VON MINCKWITZ, Gunter, BLOHMER, Jens Uwe, JACKISCH, Christian, KAUFMANN, Manfred, KÜMMEL, Sherko, PAEPKE, Stefan, SCHNEEWEISS, Andreas, UNTCH, Michael, ZAHM, Dirk Michael, MEHTA, Keyur, LOIBL, Sibylle, DAN COSTA, Serban, DENKERT, Carsten, EIDTMANN, Holger, EIERMANN, Wolfgang, GERBER, Bernd, HANUSCH, Claus, HILFRICH, Jörn, HUOBER, Jens
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Untch, Michael, Prof, Jackisch, Christian, Prof, Schneeweiss, Andreas, Prof, Conrad, Bettina, MD, Aktas, Bahriye, MD, Denkert, Carsten, Prof, Eidtmann, Holger, MD, Wiebringhaus, Hermann, MD, Kümmel, Sherko, MD, Hilfrich, Jörn, Prof, Warm, Mathias, Prof, Paepke, Stefan, MD, Just, Marianne, MD, Hanusch, Claus, MD, Hackmann, John, MD, Blohmer, Jens-Uwe, Prof, Clemens, Michael, Prof, Darb-Esfahani, Silvia, MD, Schmitt, Wolfgang Daniel, MD, Dan Costa, Serban, Prof, Gerber, Bernd, Prof, Engels, Knut, MD, Nekljudova, Valentina, PhD, Loibl, Sibylle, Prof, von Minckwitz, Gunter, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Baselga, José, Dr, Bradbury, Ian, PhD, Eidtmann, Holger, MD, Di Cosimo, Serena, MD, de Azambuja, Evandro, MD, Aura, Claudia, MD, Gómez, Henry, MD, Dinh, Phuong, MD, Fauria, Karine, PhD, Van Dooren, Veerle, MSc, Aktan, Gursel, MD, Goldhirsch, Aron, MD, Chang, Tsai-Wang, MD, Horváth, Zsolt, MD, Coccia-Portugal, Maria, MD, Domont, Julien, MD, Tseng, Ling-Min, MD, Kunz, Georg, MD, Sohn, Joo Hyuk, MD, Semiglazov, Vladimir, MD, Lerzo, Guillermo, MD, Palacova, Marketa, MD, Probachai, Volodymyr, MD, Pusztai, Lajos, DPhil, Untch, Michael, PhD, Gelber, Richard D, PhD, Piccart-Gebhart, Martine, PhD
Published in The Lancet (British edition) (18.02.2012)
Published in The Lancet (British edition) (18.02.2012)
Get full text
Journal Article
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
de Azambuja, Evandro, Dr, Holmes, Andrew P, PhD, Piccart-Gebhart, Martine, MD, Holmes, Eileen, PhD, Di Cosimo, Serena, MD, Swaby, Ramona F, MD, Untch, Michael, MD, Jackisch, Christian, MD, Lang, Istvan, MD, Smith, Ian, MD, Boyle, Frances, MBBS, Xu, Binghe, MD, Barrios, Carlos H, MD, Perez, Edith A, MD, Azim, Hatem A, MD, Kim, Sung-Bae, MD, Kuemmel, Sherko, MD, Huang, Chiun-Sheng, MD, Vuylsteke, Peter, MD, Hsieh, Ruey-Kuen, MD, Gorbunova, Vera, MD, Eniu, Alexandru, MD, Dreosti, Lydia, MD, Tavartkiladze, Natalia, MD, Gelber, Richard D, PhD, Eidtmann, Holger, MD, Baselga, José, MD
Published in The lancet oncology (01.09.2014)
Published in The lancet oncology (01.09.2014)
Get full text
Journal Article
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial
Riethdorf, Sabine, Müller, Volkmar, Loibl, Sibylle, Nekljudova, Valentina, Weber, Karsten, Huober, Jens, Fehm, Tanja, Schrader, Iris, Hilfrich, Jörn, Holms, Frank, Tesch, Hans, Schem, Christian, von Minckwitz, Gunter, Untch, Michael, Pantel, Klaus
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
UNTCH, Michael, FASCHING, Peter A, STICKELER, Elmar, HARBECK, Nadia, HÖSS, Cornelia, KAHLERT, Steffen, BECK, Thomas, FETT, Werner, MEHTA, Keyur M, VON MINCKWITZ, Gunter, LOIBL, Sibylle, KONECNY, Gottfried E, HASMÜLLER, Stephan, LEBEAU, Annette, KREIENBERG, Rolf, CAMARA, Oumar, MÜLLER, Volkmar, DU BOIS, Andreas, KÜHN, Thorsten
Published in Journal of clinical oncology (01.09.2011)
Published in Journal of clinical oncology (01.09.2011)
Get full text
Journal Article
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
RIETHDORF, Sabine, MÜLLER, Volkmar, HILFRICH, Jörn, HOLMS, Frank, TESCH, Hans, EIDTMANN, Holger, UNTCH, Michael, VON MINCKWITZ, Gunter, PANTEL, Klaus, LILING ZHANG, RAU, Thomas, LOIBL, Sibylle, KOMOR, Martina, ROLLER, Marc, HUOBER, Jens, FEHM, Tanja, SCHRADER, Iris
Published in Clinical cancer research (01.05.2010)
Published in Clinical cancer research (01.05.2010)
Get full text
Journal Article
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Goldhirsch, Aron, Prof, Gelber, Richard D, Prof, Piccart-Gebhart, Martine J, Prof, de Azambuja, Evandro, MD, Procter, Marion, MSci, Suter, Thomas M, Prof, Jackisch, Christian, Prof, Cameron, David, Prof, Weber, Harald A, MD, Heinzmann, Dominik, PhD, Lago, Lissandra Dal, MD, McFadden, Eleanor, MA, Dowsett, Mitch, Prof, Untch, Michael, Prof, Gianni, Luca, MD, Bell, Richard, Prof, Köhne, Claus-Henning, Prof, Vindevoghel, Anita, MD, Andersson, Michael, MD, Brunt, A Murray, MD, Otero-Reyes, Douglas, MD, Song, Santai, MD, Smith, Ian, Prof, Leyland-Jones, Brian, PhD, Baselga, Jose, Prof
Published in The Lancet (British edition) (21.09.2013)
Published in The Lancet (British edition) (21.09.2013)
Get full text
Journal Article
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
von Minckwitz, Gunter, Eidtmann, Holger, Rezai, Mahdi, Fasching, Peter A, Tesch, Hans, Eggemann, Holm, Schrader, Iris, Kittel, Kornelia, Hanusch, Claus, Kreienberg, Rolf, Solbach, Christine, Gerber, Bernd, Jackisch, Christian, Kunz, Georg, Blohmer, Jens-Uwe, Huober, Jens, Hauschild, Maik, Fehm, Tanja, Müller, Berit Maria, Denkert, Carsten, Loibl, Sibylle, Nekljudova, Valentina, Untch, Michael
Published in The New England journal of medicine (26.01.2012)
Published in The New England journal of medicine (26.01.2012)
Get full text
Journal Article
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
GUARNERI, Valentina, FRASSOLDATI, Antonio, UNTCH, Michael, ORLANDO, Laura, ARTIOLI, Fabrizio, BONI, Corrado, GIULIO GENERALI, Daniele, SERRA, Patrizia, BAGNALASTA, Michela, MARINI, Luca, PIACENTINI, Federico, D'AMICO, Roberto, BOTTINI, Alberto, CONTE, Pierfranco, CAGOSSI, Katia, BISAGNI, Giancarlo, SARTI, Samanta, RAVAIOLI, Alberto, CAVANNA, Luigi, GIARDINA, Giovanni, MUSOLINO, Antonino
Published in Journal of clinical oncology (01.06.2012)
Published in Journal of clinical oncology (01.06.2012)
Get full text
Journal Article
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Gianni, Luca, Prof, Dafni, Urania, Prof, Gelber, Richard D, Prof, Azambuja, Evandro, PhD, Muehlbauer, Susanne, PhD, Goldhirsch, Aron, Prof, Untch, Michael, Prof, Smith, Ian, Prof, Baselga, José, Prof, Jackisch, Christian, Prof, Cameron, David, Prof, Mano, Max, MD, Pedrini, José Luiz, MD, Veronesi, Andrea, Prof, Mendiola, Cesar, MD, Pluzanska, Anna, Prof, Semiglazov, Vladimir, MD, Vrdoljak, Eduard, MD, Eckart, Michael J, MD, Shen, Zhenzhou, Prof, Skiadopoulos, George, MSci, Procter, Marion, MSci, Pritchard, Kathleen I, MD, Piccart-Gebhart, Martine J, PhD, Bell, Richard, MBBS
Published in The lancet oncology (01.03.2011)
Published in The lancet oncology (01.03.2011)
Get full text
Journal Article
Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial
Issa-Nummer, Yasmin, Darb-Esfahani, Silvia, Loibl, Sibylle, Kunz, Georg, Nekljudova, Valentina, Schrader, Iris, Sinn, Bruno Valentin, Ulmer, Hans-Ullrich, Kronenwett, Ralf, Just, Marianne, Kühn, Thorsten, Diebold, Kurt, Untch, Michael, Holms, Frank, Blohmer, Jens-Uwe, Habeck, Jörg-Olaf, Dietel, Manfred, Overkamp, Friedrich, Krabisch, Petra, von Minckwitz, Gunter, Denkert, Carsten
Published in PloS one (02.12.2013)
Published in PloS one (02.12.2013)
Get full text
Journal Article
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof
Published in The lancet oncology (01.02.2012)
Published in The lancet oncology (01.02.2012)
Get full text
Journal Article